# U.S. IPO Weekly Recap: Biotechs City Therapeutics And Iambic Headline

> City Therapeutics and Iambic headline priced at $1.0 billion market cap.
- Title: U.S. IPO Weekly Recap: Biotechs City Therapeutics And Iambic…
- Summary: City Therapeutics and Iambic headline priced at $1.0 billion market cap. City Therapeutics priced its upsized IPO at $1.0 billion market cap to raise $200…
- Keywords: city therapeutics, iambic headline, ipo, spac, market cap, us ipo, money, business, Weekly, Recap, Biotechs, City
- Source: Seekingalpha — https://seekingalpha.com/article/4954927-us-ipo-biotechs-city-therapeutics-iambic-headline-weeks-pricings
- Author: Renaissance Capital IPO Research
- Published: 2026-10-17T04:30:00+00:00
- Read time: 1 min
- Topics: city therapeutics, iambic headline, ipo, spac, market cap, us ipo, money, business
## IPO Activity
Three IPOs and two SPACs priced this week, and two SPACs submitted filings.
## City Therapeutics Pricing
City Therapeutics priced its upsized IPO at the midpoint to raise $200 million at a $1.0 billion market cap.
## Upcoming Events
No IPOs are currently scheduled for the week ahead as the year’s next mega IPO potentially comes into view.
## Key takeaway

City Therapeutics priced its upsized IPO at $1.0 billion market cap to raise $200 million.